Author

Stefan Daniluk

Observed name: S. Daniluk

OpenAlex ID: A5033588673

Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study

2019 · Sudha Visvanathan, Stefan Daniluk, et al. · Annals of the Rheumatic Diseases · 61

Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study

2023 · Kim A. Papp, Mark G. Lebwohl, et al. · BioDrugs · 33

The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland

2011 · Janusz E. Badurski, John A. Kanis, et al. · Polskie Archiwum Medycyny Wewnętrznej · 14

Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study

2025 · Mark G. Lebwohl, John Y. Koo, et al. · Advances in Therapy · 7

FRI0161 A Phase 1B/2A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XMAB®5871 in Patients with Rheumatoid Arthritis

2015 · M. Jaraczewska-Baumann, M. Korkosz, et al. · Annals of the Rheumatic Diseases · 6

Multiple Switches Between Adalimumab-fkjp and Reference Adalimumab in Moderate-to-Severe Chronic Plaque Psoriasis: A Multicenter, Double-Blind, Parallel Group, Randomized Clinical Trial for Interchangeability

2025 · Sarika Deodhar, Subramanian Loganathan, et al. · Advances in Therapy · 5

SAT0147 Safety and Efficacy of BI 655064, An Antagonistic Anti-CD40 Antibody in Rheumatoid Arthritis (RA) Patients

2016 · S. Daniluk, R. Ptaszynski, et al. · Annals of the Rheumatic Diseases · 5

The characteristics of osteoporotic fractures in the region of Bialystok (BOS-2). The application of the WHO algorithm, FRAX®BMI and FRAX®BMD assessment tools to determine patients for intervention.

2011 · Janusz Badurski, Elżbieta Jeziernicka, et al. · PubMed · 4

Osteoarthrology Bialystok osteoporosis study-2: epidemiology of osteoporotic fractures and 10 year fracture risk assessment in population of women in Bialystok region by FRAX™ – WHO algorithm

2008 · J Badurski, Andrzej Dobreńko, et al. · Reumatologia/Rheumatology · 3

CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study

2025 · David M. Pariser, Mark G. Lebwohl, et al. · Dermatology and Therapy · 1

SAT0254 Safety and Tolerability of the Anti-C5ar Humanised Monoclonal Antibody NNC0151-0000 in Patients with Rheumatoid Arthritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Trial

2014 · S. Daniluk, B.K. Skrumsager, et al. · Annals of the Rheumatic Diseases · 1

Efficacy and Safety of CT‐P43, a Candidate Ustekinumab Biosimilar, in Moderate‐to‐Severe Plaque Psoriasis: 52‐Week Results From a Randomised, Active‐Controlled, Double‐Blind, Phase III Study

2026 · Kim A. Papp, Janusz Jaworski, et al. · Dermatologic Therapy

59550 Pharmacokinetics, Efficacy and Safety after Multiple Switches from Reference Adalimumab to Adalimumab Biosimilar (CT-P17) in comparison with the Maintenance Group (Reference Adalimumab) in Patients with Moderate-to-Severe Plaque Psoriasis: Week 52 Results

2025 · Mark Lebwohl, David Pariser, et al. · Journal of the American Academy of Dermatology

Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study

2025 · Mark G. Lebwohl, John Y. Koo, et al. · Advances in Therapy

Genetically determined and acquired factors predisponing to osteoarthritis or osteoporosis

2012 · J Badurski, Elżbieta Jeziernicka, et al. · Postępy Nauk Medycznych

Antiosteoarthritic effect of estrogen β-receptor modulator in postmenopausal women with knee osteoarthritis and osteopenia. A pilot study

2012 · Stefan Daniluk · Postępy Nauk Medycznych

Works count: 16

Citation count: 140

H-index: 5

I10-index: 3